[go: up one dir, main page]

AP2012006119A0 - Pharmaceutical composition of isoniazid. - Google Patents

Pharmaceutical composition of isoniazid.

Info

Publication number
AP2012006119A0
AP2012006119A0 AP2012006119A AP2012006119A AP2012006119A0 AP 2012006119 A0 AP2012006119 A0 AP 2012006119A0 AP 2012006119 A AP2012006119 A AP 2012006119A AP 2012006119 A AP2012006119 A AP 2012006119A AP 2012006119 A0 AP2012006119 A0 AP 2012006119A0
Authority
AP
ARIPO
Prior art keywords
isoniazid
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
AP2012006119A
Inventor
Manthan Rohitkumar Trivedi
Deepak Dineshchandra Bhatt
Bakulesh Mafatlal Khamar
Original Assignee
Cadila Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Pharmaceuticals Ltd filed Critical Cadila Pharmaceuticals Ltd
Publication of AP2012006119A0 publication Critical patent/AP2012006119A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2012006119A 2009-07-31 2010-07-29 Pharmaceutical composition of isoniazid. AP2012006119A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1765MU2009 2009-07-31
IN1991MU2009 2009-09-01
PCT/IB2010/001871 WO2011012987A1 (en) 2009-07-31 2010-07-29 Pharmaceutical composition of isoniazid

Publications (1)

Publication Number Publication Date
AP2012006119A0 true AP2012006119A0 (en) 2012-02-29

Family

ID=43528828

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2012006119A AP2012006119A0 (en) 2009-07-31 2010-07-29 Pharmaceutical composition of isoniazid.

Country Status (4)

Country Link
AP (1) AP2012006119A0 (en)
RU (1) RU2012105674A (en)
WO (1) WO2011012987A1 (en)
ZA (1) ZA201200659B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2672879C2 (en) 2013-07-26 2018-11-20 Санофи Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and process for preparation thereof
HK1218861A1 (en) * 2013-07-26 2017-03-17 Sanofi Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
EP3773731A1 (en) 2018-04-05 2021-02-17 Cipla Limited Pharmaceutical formulations
CN112438951A (en) * 2019-08-28 2021-03-05 重庆华邦制药有限公司 Method for preparing isoniazid preparation and preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0650728B1 (en) * 1993-10-29 2002-02-27 Council of Scientific and Industrial Research Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug
MXPA02003596A (en) * 2000-08-09 2003-10-14 Panacea Biotec Ltd Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation.

Also Published As

Publication number Publication date
RU2012105674A (en) 2013-09-10
ZA201200659B (en) 2012-10-31
WO2011012987A1 (en) 2011-02-03

Similar Documents

Publication Publication Date Title
IL215451A0 (en) Pharmaceutical composition
ZA201108697B (en) Quinoline derivatives-containing pharmaceutical composition
SG2014012462A (en) Pharmaceutical compositions
PL3246018T3 (en) Pharmaceutical composition
EP2379077A4 (en) Pharmaceutical composition
SMT201700008T1 (en) Pharmaceutical composition
ZA201207375B (en) Stabilized pharmaceutical composition
ZA201104670B (en) Pharmaceutical composition comprising aleglitazar
PL2298090T3 (en) Pharmaceutical or nutraceutical composition
AP2012006119A0 (en) Pharmaceutical composition of isoniazid.
GB0902648D0 (en) Pharmaceutical compounds and compositions
IL219018A0 (en) Pharmaceutical compositions
GB201001911D0 (en) Pharmaceutical composition
GB0919650D0 (en) Pharmaceutical composition
GB0908317D0 (en) Pharmaceutical compounds and compositions
AP2012006117A0 (en) Pharmaceutical composition of rifampicin.
HU0900010D0 (en) Improved pharmaceutical composition
GB0901241D0 (en) Pharmaceutical compositions
HU1000006D0 (en) Improved pharmaceutical composition
GB0908970D0 (en) Local pharmaceutical compositions
GB0902428D0 (en) Pharmaceutical methods & compositions
GB0921139D0 (en) Pharmaceutical methods & compositions
HU0800741D0 (en) Improved pharmaceutical composition
GB0903945D0 (en) Pharmaceutical compounds and compositions
GB0919055D0 (en) Pharmaceutical compounds and compositions